While early and from a small trial, the findings suggest Janux’s method of “masking” T cell engagers could lead to ...

The company reached a deal to divest its third biosimilar this year, selling a copycat version of Amgen’s Neulasta for up to ...

Today, Industry Dive, the company behind BioPharma Dive, is combining with TechTarget’s technology websites and Informa ...

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that ...

BALTIMORE, MD, December 3, 2024 — Sapio Sciences, the science-awareTM lab informatics platform, today announced that evitria, a leader in antibody expression services, has selected Sapio’s Electronic ...